Mednow
strategic acquisition of canada and liver specialty group group | Mednow
Company
Deck Type
Deck date
July 2022
Slide
43 of 44
Similar slides by Mednow
See diffirences between slides (animation)
Investor Presentation
May 2022
strategic acquisition of canada and liver specialty group acquires canada acquires liver specialty group adds specialty pharmacy to offering biologic drugs make up of patented pharmaceutical sales in canada increases specialty pharmacy services and to include hepatology and the treatment of liver disease in of top selling patented pharmaceuticals were biologic drugs compared to in services over patient visits annually both virtually and in person expands logistical infrastructure in southwestern by increasing more densely populated cities in hepatitis medications accounted for the third class of drug by percentage of public drug spending in canada | Mednow
Other recent decks by Mednow
See all presentations (7 decks)
Investor Presentation
August 2023
Investor Presentation
June 2023
Investor Presentation
January 2023
Investor Presentation
November 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights